person · Reporting owner
Reilly Thomas Charles
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMARIN CORP PLC\UKAMRN · Entity 5970 | EVP and CFO | July 01, 2024 | July 01, 2024 |
| Tvardi Therapeutics, Inc.CARA · Entity 7579 | Chief Financial Officer | March 03, 2022 | March 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMARIN CORP PLC\UK
Report date July 01, 2024 · Filed July 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 94,305 |
Last balance in matching sequence
After 2024-07-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-07-01 · Exercise / conversion · Acquired 16,667 · Balance 102,514 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F3: Not applicable Row 2 · 2024-07-01 · Tax withholding · Disposed 8,209 · Balance 94,305 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,666 |
Reported balance
After 2024-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-01 · Exercise / conversion · Disposed 16,667 · Balance 16,666 F5: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F3: Not applicable F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer.
F3: Not applicable
F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F5: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
Tvardi Therapeutics, Inc.
Report date March 03, 2022 · Filed March 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,811 |
Reported balance
After 2022-03-03 transaction · row 1
1 source rowRow 1 · 2022-03-03 · Sale · Disposed 2,044 · Balance 37,811 F1: This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on June 14, 2021 to satisfy the tax withholding obligations triggered by the vesting of performance-based RSUs reported in the Form 4 filed with the Securities and Exchange Commission on March 1, 2022, and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on June 14, 2021 to satisfy the tax withholding obligations triggered by the vesting of performance-based RSUs reported in the Form 4 filed with the Securities and Exchange Commission on March 1, 2022, and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2024 Filed Jul 1, 2024 20:54 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-079717 · ownership.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,666 Underlying: Ordinary Shares · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · kind: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F2 · derivative.exercise_date: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 01, 2024 Filed Jul 1, 2024 20:54 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 8,209 | $0.69 | $5,664.21 |
DisclosureSEC source: 0000950170-24-079717 · ownership.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,305 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| July 01, 2024 Filed Jul 1, 2024 20:54 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-079717 · ownership.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F3 · price: Not applicable Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 33,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076300 · ownership.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,333 Underlying: Ordinary Shares · 33,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · kind: On July 1, 2022, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F2 · derivative.exercise_date: On July 1, 2022, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 16,417 | $0.73 | $11,984.41 |
DisclosureSEC source: 0000950170-24-076300 · ownership.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,847 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 33,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-076300 · ownership.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On July 1, 2022, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F3 · price: Not applicable Read SEC document |
| February 01, 2024 Filed Feb 9, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 418,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0000950170-24-013289 · ownership.xml · derivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,000 Underlying: Ordinary Shares · 418,000 shares Expires 2034-02-01 F5 · derivative.exercise_date: On February 1, 2024, the Reporting Person was granted an option to purchase 418,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each April, July, October and January. F4 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2024 Filed Feb 9, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 116,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-013289 · ownership.xml · derivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,000 Underlying: Ordinary Shares · 116,000 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2024, the Reporting Person was granted 116,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2025, January 31, 2026 and January 31, 2027. F3 · derivative.expiration_date: Not applicable F4 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 44,933 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010534 · ownership.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,867 Underlying: Ordinary Shares · 44,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 24,552 | $1.24 | $30,444.48 |
DisclosureSEC source: 0000950170-24-010534 · ownership.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,931 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 44,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010534 · ownership.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F3 · price: Not applicable Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:27 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Unit · Derivative | 51,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-004305 · ownership.xml · derivative · entry 4 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:27 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Unit · Derivative | 51,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-004305 · ownership.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 51,500 shares Expires not disclosed F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · derivative.expiration_date: Not applicable F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:27 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 28,325 | $0.97 | $27,475.25 |
DisclosureSEC source: 0000950170-24-004305 · ownership.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,550 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 10, 2024 Filed Jan 12, 2024 22:27 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 51,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-004305 · ownership.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · EVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 21, 2023, the Reporting Person was granted 103,000 RSUs under the Amarin Corporation plc 2020 Stock Incentive Plan, which vest upon achievement of certain performance-based milestones and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. On January 10, 2024, the first of two performance-based milestones was achieved based on a predetermined formula tied to company cash balance as determined by the Issuer's Remuneration Committee of its Board of Directors, resulting in the vesting of 51,500 RSUs. F3 · price: Not applicable Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:01 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 404,400 | $1.08 Strike: $1.08 | $436,752.00 |
DisclosureSEC source: 0000950170-23-033855 · ownership.xml · derivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,400 Underlying: Ordinary Shares · 404,400 shares Expires 2033-07-19 F1 · derivative.exercise_date: On July 19, 2023, the Reporting Person was granted an option to purchase 404,400 Ordinary Shares under the Plan. The shares subject to this option shall vest 50% on January 1, 2024 and 50% on January 1, 2025. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:46 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 16,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016904 · doc4.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,333 Underlying: Ordinary Shares · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · kind: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F2 · derivative.exercise_date: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:46 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 8,209 | $1.19 | $9,768.71 |
DisclosureSEC source: 0000899243-23-016904 · doc4.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,375 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:46 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-016904 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. F3 · price: Not applicable. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:10 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 33,334 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016257 · doc4.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,666 Underlying: Ordinary Shares · 33,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · kind: On July 1, 2022, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F2 · derivative.exercise_date: On July 1, 2022, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:10 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 16,417 | $1.19 | $19,536.23 |
DisclosureSEC source: 0000899243-23-016257 · doc4.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,917 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:10 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 33,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-016257 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: On July 1, 2022, the Reporting Person was granted 100,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F3 · price: Not applicable. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 02:43 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-006079 · doc4.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires not disclosed F3 · security: Each Restricted Stock Units ("RSUs") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: On July 1, 2022 (the "Grant Date"), the Reporting Person was granted RSUs under the Plan, which only vest subject to the achievement of certain performance-based milestones disclosed in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on May 24, 2022 and subject to the Reporting Person's continued service with the Issuer as provided in the RSU Award Agreement between the Issuer and Reporting Person. This RSU Award also provides that if performance metrics are achieved prior to the 3rd anniversary of the Grant Date, the achieved portion of such RSU Award shall also be subject to time-based vesting such that 1/3 of such amount shall become vested on each of the first, second and third anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer. F7 · derivative.exercise_date: (Continued from Footnote 6) The Issuer's Remuneration Committee of its Board certified the achievement of performance effective as of February 21, 2023, which will result in 50,000 RSUs scheduled to vest on each of the first, second and third anniversary of the Grant Date. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 02:43 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 134,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-006079 · doc4.xml · derivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,800 Underlying: Ordinary Shares · 134,800 shares Expires not disclosed F3 · security: Each Restricted Stock Units ("RSUs") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted 134,800 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2024, January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 02:43 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 269,600 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0000899243-23-006079 · doc4.xml · derivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,600 Underlying: Ordinary Shares · 269,600 shares Expires 2033-02-21 F1 · derivative.exercise_date: On February 21, 2023, the Reporting Person was granted an option to purchase 269,600 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (as amended, the "Plan"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on the first anniversary of the grant date and the balance to vest ratably over the subsequent 12 calendar quarters on the last day of each April, July, October and January. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:11 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 100,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005610 · primarydocument.xml · derivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F4 · derivative.exercise_date: On July 1, 2022, the Reporting Person was granted 100,000 RSUs under the 2020 Plan. These RSUs vest in three equal installments on each of June 20, 2023, June 20, 2024 and June 20, 2025. F5 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:11 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001562180-22-005610 · primarydocument.xml · derivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 100,000 shares Expires 2032-07-01 F1 · derivative.exercise_date: On July 1, 2022, the Reporting Person was granted an option to purchase 100,000 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). The shares subject to this option shall vest and become exercisable over four years, with 25% to vest on June 20, 2023 and the balance to vest ratably over the subsequent 12 calendar quarters on the twentieth (20th) day of each September, December, March and June. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 22:54 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | SaleCommon Stock | 2,044 | $11.38 | $23,260.72 |
DisclosureSEC source: 0001209191-22-016438 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,811 F1 · kind: This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on June 14, 2021 to satisfy the tax withholding obligations triggered by the vesting of performance-based RSUs reported in the Form 4 filed with the Securities and Exchange Commission on March 1, 2022, and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:18 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | GrantCommon Stock | 5,333 | $10.29 | $54,876.57 |
DisclosureSEC source: 0001209191-22-013992 · doc4.xml · nonDerivative · entry 2 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,855 F2 · shares: Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on February 28, 2022. The vested shares represents the last of three possible vesting events of the total number of shares subject to the award. Each RSU represents the contingent right to receive one share of common stock of the Issuer. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:18 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $10.46 | $0.00 |
DisclosureSEC source: 0001209191-22-013992 · doc4.xml · derivative · entry 3 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-25 F3 · derivative.exercise_date: The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on March 25, 2022, in each case subject to the Reporting Person's continued service as of each such date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:18 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013992 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,522 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in three equal annual installments on each of February 25, 2023, February 25, 2024 and February 25, 2025, in each case, subject to the Reporting Person's continued service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:26 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | GrantCommon Stock | 11,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070801 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,522 F1 · shares: Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest as to (i) 50% on December 15, 2022; and (ii) 50% on June 15, 2023, subject to the Reporting Person's continued service with the Issuer through each such vesting date. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 22:08 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | SaleCommon Stock | 1,982 | $14.20 | $28,144.40 |
DisclosureSEC source: 0001209191-21-054303 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,352 F1 · kind: This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on June 14, 2021 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 22:18 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | GrantCommon Stock | 5,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053538 · doc4.xml · nonDerivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,334 F1 · shares: Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on August 24, 2021. The vested shares represents the first of three possible vesting events of the total number of shares subject to the award. The remaining shares subject to the award will vest only upon the satisfaction of additional performance vesting criteria. Each RSU represents the contingent right to receive one share of common stock of the Issuer. Read SEC document |
| October 01, 2020 Filed Oct 7, 2020 20:50 UTC | Tvardi Therapeutics, Inc. CARA · Entity 7579 | GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $12.74 | $0.00 |
DisclosureSEC source: 0001209191-20-054142 · doc4.xml · derivative · entry 1 Reilly Thomas Charles · CIK 0001827590 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-10-01 F1 · derivative.exercise_date: 25% of the shares vest and become exercisable on October 1, 2021; the balance of the shares vest and become exercisable in a series of 36 successive equal monthly installments at the end of each calendar month thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.